Eli Lilly & Co. (LLY) Shares Slide After Missing Estimates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Eli Lilly & Co. (LLY) Misses Q2 EPS by 46c, Revenue Misses
August 4, 2022 6:27 AM EDTEli Lilly & Co. (NYSE: LLY) reported Q2 EPS of $1.25, $0.46 worse than the analyst estimate of $1.71. Revenue for the quarter came in at $6.49 billion versus the consensus estimate of $6.85 billion.
GUIDANCE:
Eli Lilly & Co. sees FY2022 EPS of $7.90-$8.05, versus the... More
Eli Lilly & Co. (LLY) to Charge $2,100 Per Dose of Bebtelovimab Antibody Drug - WSJ
August 3, 2022 3:13 PM EDTLilly (NYSE: LLY) to Charge List Price of $2,100 Per Dose of Bebtelovimab Antibody Drug -- WSJ
to Start Commercial Distribution of Covid-19 Antibody Treatment Week of Aug. 15... More